NCI TTC and the Frederick National Laboratory for Cancer Research (FNLCR) will host the 2019 Technology Showcase on June 12....

Advances in the rapidly growing field of immunotherapy are being realized as evidenced by several ground-breaking, new...

TTC's Sidra Ahsan, Ph.D., received the FLC MAR 2018 "Rookie of the Year Award," presented at the FLC MAR...

The Food and Drug Administration (FDA) approved moxetumomab pasudotox (Lumoxiti), a bacterial toxin–based drug, for the...